This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Casey, G. Articles by Buggy, D. J. Search for Related Content PubMed PubMed Citation Articles by Casey, G. Articles by Buggy, D. J.

---

PAIN MEDICINE

Perioperative Nimodipine and Postoperative Analgesia

Gerri Casey, SRN^*, Sally-Ann Nortcliffe, FRCA^*, Paul Sharpe, FRCA^*, and D. J. Buggy, MD, MSc, DME, FRCPI, FCA(Irel), FRCA

*Departments of Anaesthesia, Critical Care and Pain Management, University Hospitals of Leicester, Leicester General Hospital, Leicester LE5 4PW, UK and Mater Misericordiae University Hospital, Dublin 7, Ireland and Outcomes Research^TM Institute, Louisville, Kentucky

Address correspondence to Donal Buggy, MD, Department of Anaesthesia, Mater Misericordiae University Hospital, Dublin 7, Ireland. Address e-mail to donal.buggy{at}nbsp.ie. Reprints will not be available from the author.

There is experimental evidence that nimodipine, an L-type dihydropiridine calcium channel blocker with relatively high blood-brain barrier penetration, enhances the antinociceptive properties of morphine. We tested the hypothesis that oral nimodipine taken preoperatively and 6 hourly for 48 h postoperatively would reduce visual analog scale pain scores and morphine consumption in morphine-naive patients with acute postoperative pain. Forty patients undergoing total knee replacement surgery (age 70 ± 7 yr, 28 male) were randomized by computer-generated numbers to receive capsules containing either nimodipine 30 mg or placebo in a double-blind study design. All patients received 3 capsules (nimodipine 90 mg or placebo) 1–2 h before induction of anesthesia followed by oral nimodipine 30 mg or placebo 6 hourly for 48 hours postoperatively. Spinal anesthesia was induced with hyperbaric bupivacaine 0.5% (2.4–3.0 mL) and fluids and ephedrine were given at the discretion of the anesthesiologist. Morphine patient-controlled analgesia (PCA, bolus 1 mg, lockout 5 min) was given for postoperative analgesia. Primary outcome measures were visual analog pain scores at rest and on moving (sitting forward) and PCA morphine consumption. Morphine consumption was significantly larger in nimodipine patients at 12 h (39 ± 18 versus 29 ± 15; P = 0.04), 24 h (62 ± 23 versus 45 ± 24; P = 0.02), and 48 h (88 ± 34 versus 61 ± 27; P = 0.01). There were no significant differences in pain scores at rest or moving or in time to first use of morphine analgesia. This study has demonstrated increased morphine consumption after 12 h in postoperative patients receiving nimodipine, suggesting that, in patients undergoing knee replacement surgery, it has no adjunctive analgesic effect and may actually inhibit the analgesic effect of morphine.